Rendering the findings by Dey et al. that interaction between RAC2 and inducible nitric oxide synthase (iNOS) may provoke NO upregulation and consequently initiate chronic inflammation in the RA synovium, application of therapeutic strategies focusing on RAC2 inhibition can exert beneficial effects in RA patients [219]. This evidence concerns the gene NOS2 and rheumatoid arthritis.